WASHINGTON, D.C. — November 18, 2026 — Actress and breast cancer survivor Olivia Munn has joined Arizona Senator Mark Kelly in introducing the Know Your Risk Act, a bipartisan proposal aimed at making breast cancer risk assessments a routine part of healthcare so women can better understand their personal risk and access appropriate early-detection options. The announcement was made at a Washington press conference on Wednesday. KYMA reported on the announcement, while Senator Kelly’s office previously outlined the effort.

Munn Turns Her Personal Experience Into Advocacy
Munn’s involvement is rooted in her own experience with breast cancer. She has spoken publicly about receiving a diagnosis in 2023 after a risk assessment indicated that her lifetime risk was elevated, despite earlier routine screening and genetic testing not raising the same concern. A subsequent MRI detected tumours, and she underwent treatment that included a double mastectomy. PEOPLE’s recent interview with Munn details how that experience shaped her decision to advocate for wider access to risk-assessment tools.
The assessment she took estimated her lifetime risk at 37.3 per cent using the Tyrer-Cuzick model. Munn has also described how the information helped her family take further medical steps. Her message is that women should have meaningful conversations with healthcare professionals about individual risk, rather than assuming a normal mammogram or an unremarkable genetic test tells the whole story. Read the PEOPLE interview.
What The Know Your Risk Act Seeks To Achieve

The proposal seeks to make breast cancer risk assessment a more familiar and consistent part of routine medical care. Its supporters say that women should have better opportunities to understand their personal risk and, where appropriate, discuss additional screening, genetic counselling or risk-reduction options with their healthcare providers. KYMA’s coverage describes the bipartisan announcement and its focus on early detection.
Senator Kelly has previously said the effort would address access to risk-assessment tools and examine their accuracy. His office discussed plans for a task force and federal research in an earlier briefing on the legislation. The precise implementation will depend on the bill text and the legislative process; the proposal has not become law simply by being introduced. Kelly’s office provides background on the proposal.
Why Risk Assessments Matter
Breast cancer risk assessment tools use personal and family health information, alongside other factors depending on the model, to estimate a person’s likelihood of developing breast cancer. These tools do not diagnose cancer or predict with certainty who will develop it. Instead, they can help clinicians identify people who may benefit from a more personalised screening discussion. The National Cancer Institute explains cancer risk factors and the role of risk assessment in understanding risk.
For some women at higher risk, healthcare professionals may recommend additional screening such as breast MRI alongside mammography. The appropriate approach depends on a person’s medical history and risk profile. The American Cancer Society’s screening guidance explains screening options and considerations for women at increased risk.
A Wider Conversation About Women’s Healthcare
The partnership between Munn and Kelly brings personal experience and legislative advocacy into a wider conversation about women’s health. Kelly has also spoken about breast cancer in his family, including diagnoses affecting his mother and grandmother. His office has described the personal motivation behind the collaboration.
If adopted, a more routine approach to risk assessment could encourage earlier conversations between patients and clinicians and help some women access screening options suited to their individual circumstances. The proposal’s ultimate impact will depend on congressional consideration, the final legislative language and how any resulting policy is implemented.
Editorial note: A breast cancer risk score is not a diagnosis, and no assessment can guarantee that a person will or will not develop cancer. Women should discuss personal screening decisions with qualified healthcare professionals.
HeadlinesXtra — Bringing The Headlines Closer To You!